
Alterity Therapeutics Limited ATHE
$ 4.2
0.24%
Annual report 2022
added 08-31-2022
Country |
![]() |
IPO year |
- |
Industry |
Biotechnology |
Stock Exchange |
NASDAQ CAPITAL |
CEO |
Mr. Geoffrey Paul Kempler |
Employees in the company |
12 |
Shares |
2.41 B |
Market Cap[1] |
$ 10.1 B |
EBITDA (LTM) |
- |
P/E (LTM) |
- |
P/S (LTM) |
- |
EPS (LTM) |
- |
Other stocks of industry "Biotechnology"
References
- Pavone, P. (2019). Market capitalization and financial variables: Evidence from Italian listed companies. International Journal of Academic Research Business and Social Sciences, 9(3), 1356-1371.